Notes from the Field: Rollout of Nirsevimab to Protect Infants and Young Children During the Respiratory Syncytial Virus Season - New York City, 2023-2024

摘要

This report describes the percentage of New York City infants born during the recommended nirsevimab adminstration period who received nirsevimab.

This report describes the percentage of New York City infants born during the recommended nirsevimab adminstration period who received nirsevimab.

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

萃取時間: 2026-02-05T15:09:24Z 資料來源: CDC MMWR